Learn about the promising advance in prenatal treatment of spinal muscular atrophy, introducing a potential approach to suppress symptoms of the disorder in infants.

Risdiplam, an SMN2 pre-mRNA splicing modifier, enhances SMN protein production, supporting motor neuron health and function. The tablet form offers storage convenience and flexibility, expanding ...